Sorrento Therapeutics Inc.

12/05/2021 | Press release | Distributed by Public on 12/05/2021 13:33

Sorrento Announces Publication of a Series of Novel SARS-CoV-2 Main Protease (MPRO) Inhibitors for Potential Treatment of COVID-19 Patients Infected With SARS-CoV-2 Variants Of[...]